Evaluation of Periprocedural Safety and Efficacy of Dabigatran, Rivaroxaban, Apixaban and Edoxaban During Catheter Ablation for Atrial Fibrillation

被引：0
|
作者：
Tohoku, Shota
Hiroshima, Kenichi
Nagashima, Michio
Morita, Junji
Iseda, Takahiro
Ando, Kengo
Ando, Kenji
机构：
来源：
CIRCULATION | 2016年 / 134卷
关键词：
Ablation; Anticoagulants; Dabigatran; Rivoraxaban; Apixaban;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
16578
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Evaluation of safety and efficacy of periprocedural use of rivaroxaban and apixaban in catheter ablation for atrial fibrillation
    Yoshimura, Akino
    Iriki, Yasuhisa
    Ichiki, Hitoshi
    Oketani, Naoya
    Okui, Hideki
    Maenosono, Ryuichi
    Namino, Fuminori
    Miyata, Masaaki
    Ohishi, Mitsuru
    JOURNAL OF CARDIOLOGY, 2017, 69 (1-2) : 228 - 235
  • [2] Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation
    Skjoth, Flemming
    Larsen, Torben Bjerregaard
    Rasmussen, Lars Hvilsted
    Lip, Gregory Y. H.
    THROMBOSIS AND HAEMOSTASIS, 2014, 111 (05) : 981 - 988
  • [3] Evaluation of safety and efficacy of perioperative use of rivaroxaban and apixaban in catheter ablation for atrial fibrillation
    Iriki, Y.
    Ichiki, H.
    Oketani, N.
    Yoshimura, A.
    Okui, H.
    Maenosono, R.
    Namino, F.
    Miyata, M.
    Ohishi, M.
    EUROPEAN HEART JOURNAL, 2015, 36 : 687 - 687
  • [4] Efficacy and Safety of Periprocedural Dabigatran in Patients Undergoing Catheter Ablation of Atrial Fibrillation
    Kaseno, Kenichi
    Naito, Shigeto
    Nakamura, Kohki
    Sakamoto, Tamotsu
    Sasaki, Takehito
    Tsukada, Naofumi
    Hayano, Mamoru
    Nishiuchi, Suguru
    Fuke, Etsuko
    Miki, Yuko
    Nakamura, Keijiro
    Yamashita, Eiji
    Kumagai, Koji
    Oshima, Shigeru
    Tada, Hiroshi
    CIRCULATION JOURNAL, 2012, 76 (10) : 2337 - 2342
  • [5] Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation
    Chan, Yi-Hsin
    See, Lai-Chu
    Tu, Hui-Tzu
    Yeh, Yung-Hsin
    Chang, Shang-Hung
    Wu, Lung-Sheng
    Lee, Hsin-Fu
    Wang, Chun-Li
    Kuo, Chang-Fu
    Kuo, Chi-Tai
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (08):
  • [6] Apixaban, Rivaroxaban, and Dabigatran in Patients Undergoing Atrial Fibrillation Ablation
    Rillig, Andreas
    Lin, Tina
    Plesman, Joaquina
    Heeger, Christian-H.
    Lemes, Christine
    Metzner, Andreas
    Mathew, Shibu
    Wissner, Erik
    Wohlmuth, Peter
    Ouyang, Feifan
    Kuck, Karl-Heinz
    Tilz, Roland Richard
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2016, 27 (02) : 147 - 153
  • [7] PERIPROCEDURAL DABIGATRAN IN PATIENTS UNDERGOING CATHETER ABLATION FOR ATRIAL FIBRILLATION
    Khan, Saadat
    Duggal, Manoj
    Dunskis, Paula
    Bhan, Adarsh
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E401 - E401
  • [8] Rivaroxaban and dabigatran in patients undergoing catheter ablation of atrial fibrillation
    Providencia, Rui
    Marijon, Eloi
    Albenque, Jean-Paul
    Combes, Stephane
    Combes, Nicolas
    Jourda, Francois
    Hireche, Hassiba
    Morais, Joao
    Boveda, Serge
    EUROPACE, 2014, 16 (08): : 1137 - 1144
  • [9] Direct comparison of dabigatran, apixaban, rivaroxaban and edoxaban for effectiveness and safety among patients with non-valvular atrial fibrillation
    Choi, E. -K.
    Lee, S. R.
    Kwon, S.
    Han, K. D.
    Jung, J. H.
    Oh, S.
    Lip, G. Y. H.
    EUROPEAN HEART JOURNAL, 2019, 40 : 2986 - 2986
  • [10] Efficacy and safety of uninterrupted periprocedural edoxaban in patients undergoing catheter ablation for atrial fibrillation: Prospective KYU-RABLE study
    Takahashi, N.
    Mukai, Y.
    Okumura, K.
    EUROPEAN HEART JOURNAL, 2019, 40 : 164 - 164
12345